The prevalence of osteoporosis and osteoporotic fractures decreased over a 24-year period among patients with rheumatoid arthritis.

For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy.

Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.

The AAP has published its first clinical practice guideline on the use of pediatric opioid prescribing to manage acute pain in children.

The rates of sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased during the intrapandemic period.

The Food and Drug Administration has granted EYD-001 orphan drug designation for the treatment of systemic sclerosis.

Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis.

Patients with D2T RA experience more noninflammatory pain vs those without D2T disease who were responsive to treatment with b/tsDMARDs.

Zasocitinib at doses of 5 mg or greater vs placebo resulted in greater skin clearance among patients with moderate to severe plaque psoriasis.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.

Outdoor nighttime light pollution exposure is associated with a higher risk of developing Alzheimer disease, especially among younger adults.